Skip to content

Clinical trials

Phase 1/2 Breast Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 1/2 Country / region: Australia Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20091
20131
20142
20172
20183
20191
20205
20211
20226
20233
20241
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17
Active, not recruiting9
Completed5
Terminated4
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Novartis Pharmaceuticals3
Bristol-Myers Squibb2
Eli Lilly and Company2
Fermiscan Ltd2
Hoffmann-La Roche2
Pfizer2
Aminex Therapeutics, Inc.1
Antares Therapeutics, Inc1
Avenzo Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms38
Carcinoma, Non-Small-Cell Lung12
Ovarian Neoplasms11
Stomach Neoplasms8
Endometrial Neoplasms7
Lung Neoplasms7
Neoplasm Metastasis7
Colorectal Neoplasms6
Pancreatic Neoplasms6
Prostatic Neoplasms6

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.